Table of Content

1. Executive Summary
   1.1. Global Immune Checkpoint Inhibitors Market Snapshot, 2024 and 2034
   1.2. Market Opportunity Assessment, 2024 - 2034, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global GDP Growth Outlook
       2.3.2. Global Consumer Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Product Adoption Analysis
   3.2. Regulatory Landscape
   3.3. Value Chain Analysis
   3.4. Key Deals and Mergers
   3.5. PESTLE Analysis
   3.6. Porter’s Five Force Analysis
4. Global Immune Checkpoint Inhibitors Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2034)
   4.1. Global Immune Checkpoint Inhibitors Market Outlook: Type
       4.1.1. Introduction / Key Findings
       4.1.2. Historical Market Size (US$ Mn) Analysis, By Type, 2018 - 2022
       4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2023 - 2034
           4.1.3.1. PD-1
           4.1.3.2. PD-L1
           4.1.3.3. CTLA-4
   4.2. Market Attractiveness Analysis: Type
   4.3. Global Immune Checkpoint Inhibitors Market Outlook: Application
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Application, 2018 - 2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2034
           4.3.3.1. Lung Cancer
           4.3.3.2. Breast Cancer
           4.3.3.3. Melanoma
   4.4. Market Attractiveness Analysis: Application
   4.5. Global Immune Checkpoint Inhibitors Market Outlook: Distribution Channel
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2018 - 2022
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2034
           4.5.3.1. Hospital Pharmacy
           4.5.3.2. Retail Pharmacy
           4.5.3.3. Online Pharmacy
   4.6. Market Attractiveness Analysis: Distribution Channel
5. Global Immune Checkpoint Inhibitors Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2034
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Immune Checkpoint Inhibitors Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2034)
   6.1. Key Highlights
   6.2. Pricing Analysis
   6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       6.3.1. By Country
       6.3.2. By Type
       6.3.3. By Application
       6.3.4. Distribution Channel
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2034
       6.4.1. U.S.
       6.4.2. Canada
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2023 - 2034
       6.5.1. PD-1
       6.5.2. PD-L1
       6.5.3. CTLA-4
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2034
       6.6.1. Lung Cancer
       6.6.2. Breast Cancer
       6.6.3. Melanoma
   6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2034
       6.7.1. Hospital Pharmacy
       6.7.2. Retail Pharmacy
       6.7.3. Online Pharmacy
   6.8. Market Attractiveness Analysis
7. Europe Immune Checkpoint Inhibitors Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2034)
   7.1. Key Highlights
   7.2. Pricing Analysis
   7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       7.3.1. By Country
       7.3.2. By Type
       7.3.3. By Application
       7.3.4. Distribution Channel
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2034
       7.4.1. Germany
       7.4.2. France
       7.4.3. U.K.
       7.4.4. Italy
       7.4.5. Spain
       7.4.6. Russia
       7.4.7. Türkiye
       7.4.8. Rest of Europe
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2023 - 2034
       7.5.1. PD-1
       7.5.2. PD-L1
       7.5.3. CTLA-4
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2034
       7.6.1. Lung Cancer
       7.6.2. Breast Cancer
       7.6.3. Melanoma
   7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2034
       7.7.1. Hospital Pharmacy
       7.7.2. Retail Pharmacy
       7.7.3. Online Pharmacy
   7.8. Market Attractiveness Analysis
8. East Asia Immune Checkpoint Inhibitors Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2034)
   8.1. Key Highlights
   8.2. Pricing Analysis
   8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       8.3.1. By Country
       8.3.2. By Type
       8.3.3. By Application
       8.3.4. Distribution Channel
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2034
       8.4.1. China
       8.4.2. Japan
       8.4.3. South Korea
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2023 - 2034
       8.5.1. PD-1
       8.5.2. PD-L1
       8.5.3. CTLA-4
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2034
       8.6.1. Lung Cancer
       8.6.2. Breast Cancer
       8.6.3. Melanoma
   8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2034
       8.7.1. Hospital Pharmacy
       8.7.2. Retail Pharmacy
       8.7.3. Online Pharmacy
   8.8. Market Attractiveness Analysis
9. South Asia & Oceania Immune Checkpoint Inhibitors Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2034)
   9.1. Key Highlights
   9.2. Pricing Analysis
   9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       9.3.1. By Country
       9.3.2. By Type
       9.3.3. By Application
       9.3.4. Distribution Channel
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2034
       9.4.1. India
       9.4.2. Southeast Asia
       9.4.3. ANZ
       9.4.4. Rest of South Asia & Oceania
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2023 - 2034
       9.5.1. PD-1
       9.5.2. PD-L1
       9.5.3. CTLA-4
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2034
       9.6.1. Lung Cancer
       9.6.2. Breast Cancer
       9.6.3. Melanoma
   9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2034
       9.7.1. Hospital Pharmacy
       9.7.2. Retail Pharmacy
       9.7.3. Online Pharmacy
   9.8. Market Attractiveness Analysis
10. Latin America Immune Checkpoint Inhibitors Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2034)
   10.1. Key Highlights
   10.2. Pricing Analysis
   10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       10.3.1. By Country
       10.3.2. By Type
       10.3.3. By Application
       10.3.4. Distribution Channel
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2034
       10.4.1. Brazil
       10.4.2. Mexico
       10.4.3. Rest of Latin America
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2023 - 2034
       10.5.1. PD-1
       10.5.2. PD-L1
       10.5.3. CTLA-4
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2034
       10.6.1. Lung Cancer
       10.6.2. Breast Cancer
       10.6.3. Melanoma
   10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2034
       10.7.1. Hospital Pharmacy
       10.7.2. Retail Pharmacy
       10.7.3. Online Pharmacy
   10.8. Market Attractiveness Analysis
11. Middle East & Africa Immune Checkpoint Inhibitors Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2034)
   11.1. Key Highlights
   11.2. Pricing Analysis
   11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       11.3.1. By Country
       11.3.2. By Type
       11.3.3. By Application
       11.3.4. Distribution Channel
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2034
       11.4.1. GCC Countries
       11.4.2. Egypt
       11.4.3. South Africa
       11.4.4. Northern Africa
       11.4.5. Rest of Middle East & Africa
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Type, 2023 - 2034
       11.5.1. PD-1
       11.5.2. PD-L1
       11.5.3. CTLA-4
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2034
       11.6.1. Lung Cancer
       11.6.2. Breast Cancer
       11.6.3. Melanoma
   11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2034
       11.7.1. Hospital Pharmacy
       11.7.2. Retail Pharmacy
       11.7.3. Online Pharmacy
   11.8. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Sanofi
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. F. Hoffmann-La Roche Ltd.
       12.3.3. Merck & Co.
       12.3.4. Bristol-Myers Squibb Company
       12.3.5. Eli Lilly and Company
       12.3.6. Regeneron Pharmaceuticals Inc.
       12.3.7. AstraZeneca PLC
       12.3.8. Shanghai Jhunsi Biosciences Ltd
       12.3.9. Immutep Ltd
       12.3.10. BeiGene Ltd
       12.3.11. GlaxoSmithKline PLC
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations